| 15:51 | Genocea Biosciences To Wind Down Operations; Shares Fall |  |
| 14:12 | GENOCEA BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing .. | |
| 14:02 | Genocea Announces Wind Down of Operations and Delisting From NASDAQ | |
| 05/05 | GENOCEA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition .. | |
| 05/05 | Genocea Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31.. | |
| 29/04 | Top Premarket Decliners | |
| 29/04 | GENOCEA BIOSCIENCES : Initiates Restructuring and Announces Plan to Explore Strategic Alte.. | |
| 28/04 | Genocea Announces Plan to Explore Strategic Alternatives | |
| 28/04 | GENOCEA BIOSCIENCES, INC. : Costs Associated with Exit or Disposal Activities, Regulation .. | |
| 28/04 | Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives | |
| 11/04 | TRANSCRIPT : Genocea Biosciences, Inc. Presents at AACR Annual Meeting 2022, Apr-08-2022 t.. | |
| 11/04 | Wall Street Set for Losses, Surging Treasury Yield Fuels Tech Slump | |
| 11/04 | Top Premarket Gainers | |
| 11/04 | GENOCEA BIOSCIENCES : 21st Annual Needham Virtual Healthcare Conference | |
| 08/04 | TRANSCRIPT : Genocea Biosciences, Inc. - Special Call | |
| 08/04 | Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022 | |
| 08/04 | Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022 | |
| 08/04 | Genocea Biosciences, Inc. Presents Encouraging Initial Data from GEN-011 Phase 1/2a Tri.. | |
| 07/04 | GENOCEA BIOSCIENCES : Investor Webinar | |
| 04/04 | Genocea Biosciences to Host Investor Webinar | |
| 18/03 | GENOCEA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition .. | |
| 18/03 | Genocea Biosciences, Inc. Auditor Raises 'Going Concern' Doubt | |
| 16/03 | GENOCEA BIOSCIENCES : 32nd Annual Oppenheimer Healthcare Conference | |
| 14/03 | Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference | |
| 10/03 | GENOCEA BIOSCIENCES : Provides Fourth Quarter 2021 Corporate Update - Form 8-K | |
| 10/03 | TRANSCRIPT : Genocea Biosciences, Inc., Q4 2021 Earnings Call, Mar 10, 2022 | |
| 10/03 | Genocea Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year.. | |
| 10/03 | GENOCEA BIOSCIENCES : Q4 Earnings Snapshot | |
| 10/03 | Genocea Provides Fourth Quarter 2021 Corporate Update | |
| 10/03 | NORTH AMERICAN MORNING BRIEFING : Oil Prices Jump, -2- | |
| 09/03 | GENOCEA BIOSCIENCES : Fourth Quarter 2021 Financial Results | |
| 08/03 | Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting | |
| 08/03 | Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting | |
| 08/03 | Genocea Biosciences, Inc. - John Lunger, of Adaptimmune, Joins Genocea Biosciences' Boa.. | |
| 07/03 | GENOCEA BIOSCIENCES : John Lunger, of Adaptimmune, Joins Genocea Biosciences' Board of Dir.. | |
| 07/03 | GENOCEA BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement.. | |
| 07/03 | John Lunger, of Adaptimmune, Joins Genocea Biosciences' Board of Directors | |
| 07/03 | John Lunger Joins Genocea Biosciences' Board of Directors | |
| 03/03 | Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & Webcast | |
| 03/03 | NORTH AMERICAN MORNING BRIEFING : Oil Prices Top -3- | |
| 17/02 | NORTH AMERICAN MORNING BRIEFING : Stock Futures, -2- | |
| 16/02 | GENOCEA BIOSCIENCES : 11th Annual SVB Leerink Global Healthcare Conference | |
| 11/02 | Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference | |
| 09/01 | GENOCEA BIOSCIENCES : H.C. Wainwright BIOCONNECT Virtual Conference | |
| 05/01 | Genocea to Present at Upcoming Investor Conferences | |
| 04/01 | Genocea Biosciences Teams Up with Janssen to Explore Immunogenicity of Neoantigens | |
| 04/01 | GENOCEA BIOSCIENCES : Provides Corporate Update - Form 8-K | |
| 04/01 | GENOCEA BIOSCIENCES, INC. : Entry into a Material Definitive Agreement (form 8-K) | |
| 04/01 | Genocea Biosciences Provides Corporate Update | |
| 04/01 | Genocea Biosciences Provides Corporate Update | |
| 04/01 | Genocea Biosciences, Inc. Enters into an R&D Collaboration and Option Agreement with Ja.. | |
| 2021 | GENOCEA BIOSCIENCES : Stifel 2021 Virtual Healthcare Conference | |
| 2021 | Genocea to Present at the Stifel 2021 Virtual Healthcare Conference | |
| 2021 | GENOCEA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition .. | |
| 2021 | Genocea Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Month.. | |
| 2021 | GENOCEA BIOSCIENCES : Q3 Earnings Snapshot | |
| 2021 | TRANSCRIPT : Genocea Biosciences, Inc., Q3 2021 Earnings Call, Oct 28, 2021 | |
| 2021 | GEN-011 NEOANTIGEN-TARGETED PERIPHER : 30 a.m. E.T - Form 8-K | |
| 2021 | GENOCEA BIOSCIENCES, INC. : Results of Operations and Financial Condition (form 8-K) | |
| 2021 | Genocea Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Month.. | |
| 2021 | Third Quarter 2021 Financial Results | |
| 2021 | GENOCEA BIOSCIENCES : to Host Third Quarter 2021 Corporate Update Conference Call & Webcas.. | |
| 2021 | Genocea to Present at Upcoming Conferences | |
| 2021 | GENOCEA BIOSCIENCES : Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Boa.. | |
| 2021 | GENOCEA BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K) | |
| 2021 | Genocea Biosciences, Inc. Appoints Jennifer Herron to Its Board of Directors | |
| 2021 | Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Board of Directors | |
| 2021 | GENOCEA BIOSCIENCES : H.C. Wainwright 22nd Annual Global Investment Conference (virtual) | |
| 2021 | Genocea to Present at Upcoming Scientific and Investor Conferences | |
| 2021 | GENOCEA BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu.. | |
| 2021 | GENOCEA BIOSCIENCES : Q2 Earnings Snapshot | |
| 2021 | TRANSCRIPT : Genocea Biosciences, Inc., Q2 2021 Earnings Call, Jul 29, 2021 | |
| 2021 | GENOCEA BIOSCIENCES, INC. : Results of Operations and Financial Condition (form 8-K) | |
| 2021 | Genocea Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30.. | |
| 2021 | GENOCEA BIOSCIENCES : Provides Second Quarter 2021 Corporate Update | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
